Deal Announcements

Ablation Frontiers Closes $22 Million Series C

Wednesday, July 18, 2007 5:00:00 AM PDT | VentureDeal Staff

CARLSBAD, CA -- Medical device maker Ablation Frontiers, Inc. announced the close of its $21.8 million series C financing round.

The company has developed a portfolio of devices for treating arrhythmias with the use of expensive imaging systems or robotics.  The company intends to use the funding to fund the IDE clinical trial in the U.S., as well as expanding its operations worldwide.

Investors included Novartis Venture Fund, Affinity Ventures, Hexagon Investments, Trellis Health Ventures, Versant Ventures, Aberdare Ventures and Pequot Ventures.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1